Erin MacKenzie, PhD

Symptomatic and Functional Response to Brexpiprazole Treatment in Patients With Acute Schizophrenia by Age

Introduction: The efficacy and safety of brexpiprazole in the treatment of schizophrenia have been demonstrated in short- and long-term studies. This post-hoc analysis assessed the propor...

Catherine Weiss , PhD;

Stine Rasmussen Meehan , PhD;

H. Lundbeck ;

Peter Zhang , PhD;

Erin MacKenzie , PhD;

Francois Therrien , PharmD;

03/01/2019

Effects of Adjunctive Brexpiprazole on Patient Life Engagement in Major Depressive Disorder: A Phase 4, Open-Label, Interventional Study

Abstract: Background: Patient life engagement is a broad term describing positive health aspects across four domains (emotional, physical, social, cognitive). The 10-item Inventory of Dep...

Erin MacKenzie , PhD;

Liz Kelly ;

01/19/2023

Short- and Long-Term Metabolic Changes in Patients with MDD Treated with Adjunctive Brexpiprazole or Adjunctive Aripiprazole: An Indirect Comparison

Objective: We aimed to describe metabolic changes observed during short- and long-term studies of brexpiprazole and aripiprazole in patients with MDD.

Catherine Weiss , PhD;

Stine Rasmussen Meehan , PhD;

Peter Zhang , PhD;

Erin MacKenzie , PhD;

Francois Therrien , PharmD;

Ross Baker , PhD, MBA;

11/22/2019